Concepedia

Publication | Closed Access

Irinotecan and temozolomide for Ewing sarcoma: The Memorial Sloan‐Kettering experience

DOI

189

Citations

38

References

2009

Year

Denise A. Casey, Leonard H. Wexler, Melinda S. Merchant, Alexander J. Chou, Pamela R. Merola, Anita P. Price, Paul A. Meyers
Pediatric Blood & Cancer

Abstract

Irinotecan and temozolomide is a well-tolerated and active regimen for recurrent/progressive ES. Prospective trials are necessary to define the role of this regimen in newly diagnosed ES.

References

YearCitations

Page 1